Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Two experts, including Glaucoma Editor Manjool Shah, MD, spoke about the complications during and after MIGS procedures that the surgeon needs to be prepared to identify and address.
➤ FDA issues eight warning letters ➤ Positive Phase 2 safety update for investigational treatment of retinal diseases ➤ First-in-human titratable glaucoma therapy system ➤ Companies partner to develop biological dry eye treatment ➤ Geographic atrophy drug development discontinued ➤ ASCRS news and events
Neovascular glaucoma (NVG) is an aggressive, secondary glaucoma that develops in the setting of retinal ischemia. Specialists and residents weighed in on what to look for and strategies to manage this condition.
➤ Study: 1-year results with IOP-lowering implant ➤ Phase 2 study of investigational dry eye treatment nears enrollment target ➤ Study identifies antibody that could lead to retinitis pigmentosa treatment ➤ Gene therapy for inherited optic neuropathy approved for clinical trials ➤ ASCRS news and events
➤ FDA issues complete response letter for bevacizumab for retinal diseases ➤ First patient dosed in study evaluating X-linked retinoschisis ➤ Gene therapy study for Leber hereditary optic neuropathy begins dosing ➤ Update on rare retinal vasculitis events associated with GA treatment ➤ Eye drop recall grows ➤ ASCRS news and events
➤ FDA approves high-dose aflibercept ➤ Positive results in Phase 1 trial for cultivated autologous limbal epithelial cells ➤ Study: data from eye scans detect Parkinson’s disease years before clinical presentation ➤ Phase 2/3 study to evaluate persistent corneal epithelial defect treatment ➤ Phase 3 study offers results with aflibercept biosimilar ➤ ASCRS news and events
“Best practices are the summation of the technical aspects of medicine. They are, in effect, the perfection of the form of medicine,” said Julie Schallhorn, MD. She shared this and other thoughts on best practices and gave a preview of the articles in the Cornea section of the issue.
“The ASCRS Annual Meeting’s glaucoma programming and scientific content … shows me that while we have a long road ahead of us, the creativity, collaboration, and connectedness that exemplify ASCRS will help us light the way,” said Manjool Shah, MD. He shared what to expect in the Glaucoma section of the issue.
➤ FDA approves first treatment targeting Demodex ➤ Phase 1 study compares mechanical dry eye treatment to drop therapy ➤ Topical gene therapy for rare ocular surface condition ➤ Glaucoma drug licensed for commercialization in U.S. ➤ ASCRS news and events
Optimizing ocular conditions prior to surgery is standard for any procedure, but eyes with glaucoma present extra considerations. EyeWorld spoke with two ophthalmologists to get insights on how to prepare eyes with glaucoma for different ocular procedures. They also shared a few intraoperative and postop considerations along the way.
Get the latest ophthalmology news delivered to your inbox every Friday.